infexn® NGS is an advanced Next-Generation Sequencing (NGS)-based infectious disease diagnostic solution from HaystackAnalytics Private Limited. Built to aid in diagnosing complex and hard-to-solve infections, infexn® applies metagenomic Next-Generation Sequencing (mNGS) to identify a wide range of pathogens directly from clinical samples.
The technology can simultaneously detect bacteria, fungi, viruses, and antimicrobial resistance (AMR)-associated genes, delivering comprehensive insights into infectious diseases from a single test. By lessening reliance on conventional culture-based methods, infexn® NGS helps in investigating infections that routine diagnostic approaches may struggle to resolve.
Backed by its powerful sequencing capabilities, infexn® seeks to give clinicians actionable genomic insights that support well-informed clinical decisions, targeted treatment strategies, and better patient management. The solution is especially valuable in complex infections, critical care settings, and situations where rapid, comprehensive pathogen identification is essential.
infexn® NGS reflects HaystackAnalytics’ commitment to transforming infectious disease diagnostics through genomic innovation, precision medicine, and advanced molecular technologies.
FLU-NGS, Opthal-NGS, NGS, genomics